Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
American Association of Physicians in Medicine to hold a virtual meeting » 05:55
07/16/20
07/16
05:55
07/16/20
05:55
ARAY

Accuray

$2.21 /

+0.095 (+4.49%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

, VAR

Varian Medical

$126.24 /

+4.54 (+3.73%)

, VRAY

ViewRay

$2.30 /

+0.015 (+0.66%)

2020 Joint AAPM COMP…

2020 Joint AAPM COMP Virtual Meeting will be held on July 12-16. Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$2.30 /

+0.015 (+0.66%)

VAR Varian Medical
$126.24 /

+4.54 (+3.73%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

ARAY Accuray
$2.21 /

+0.095 (+4.49%)

ARAY Accuray
$2.21 /

+0.095 (+4.49%)

04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

07/02/20 JPMorgan
Siemens Healthineers price target lowered to EUR 37.60 at JPMorgan
06/08/20 Citi
Siemens Healthineers upgraded to Buy from Neutral at Citi
06/05/20 Exane BNP Paribas
Siemens Healthineers downgraded to Neutral from Outperform at Exane BNP Paribas
05/26/20 Berenberg
Siemens Healthineers price target raised to EUR 52 from EUR 40 at Berenberg
VAR Varian Medical
$126.24 /

+4.54 (+3.73%)

06/18/20 UBS
Varian Medical competitive position remains strong, says UBS
05/12/20 Piper Sandler
Piper Sandler notes goodwill impairment charge for Varian Medical investors
05/05/20 Barrington
Varian Medical price target lowered to $137 from $147 at Barrington
05/05/20 Piper Sandler
Varian Medical price target raised to $130 from $126 at Piper Sandler
VRAY ViewRay
$2.30 /

+0.015 (+0.66%)

06/23/20 Piper Sandler
Piper Sandler bullish on ViewRay as 1-year prostate data adds to data compendium
06/16/20 Cantor Fitzgerald
ViewRay assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
ViewRay assumed with an Overweight at Cantor Fitzgerald
04/28/20 Guggenheim
ViewRay downgraded to Neutral on hospital budget strain at Guggenheim
VRAY ViewRay
$2.30 /

+0.015 (+0.66%)

VAR Varian Medical
$126.24 /

+4.54 (+3.73%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

ARAY Accuray
$2.21 /

+0.095 (+4.49%)

  • 04
    Dec
BAYRY Bayer
$0.00 /

+ (+0.00%)

VRAY ViewRay
$2.30 /

+0.015 (+0.66%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

Yesterday
Conference/Events
American Association of Physicians in Medicine to hold a virtual meeting » 04:55
07/15/20
07/15
04:55
07/15/20
04:55
ARAY

Accuray

$2.12 /

+0.07 (+3.42%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

, VAR

Varian Medical

$121.70 /

+2.53 (+2.12%)

, VRAY

ViewRay

$2.28 /

+0.165 (+7.80%)

2020 Joint AAPM COMP…

2020 Joint AAPM COMP Virtual Meeting will be held on July 12-16. Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$2.28 /

+0.165 (+7.80%)

VAR Varian Medical
$121.70 /

+2.53 (+2.12%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

ARAY Accuray
$2.12 /

+0.07 (+3.42%)

ARAY Accuray
$2.12 /

+0.07 (+3.42%)

04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

07/02/20 JPMorgan
Siemens Healthineers price target lowered to EUR 37.60 at JPMorgan
06/08/20 Citi
Siemens Healthineers upgraded to Buy from Neutral at Citi
06/05/20 Exane BNP Paribas
Siemens Healthineers downgraded to Neutral from Outperform at Exane BNP Paribas
05/26/20 Berenberg
Siemens Healthineers price target raised to EUR 52 from EUR 40 at Berenberg
VAR Varian Medical
$121.70 /

+2.53 (+2.12%)

06/18/20 UBS
Varian Medical competitive position remains strong, says UBS
05/12/20 Piper Sandler
Piper Sandler notes goodwill impairment charge for Varian Medical investors
05/05/20 Barrington
Varian Medical price target lowered to $137 from $147 at Barrington
05/05/20 Piper Sandler
Varian Medical price target raised to $130 from $126 at Piper Sandler
VRAY ViewRay
$2.28 /

+0.165 (+7.80%)

06/23/20 Piper Sandler
Piper Sandler bullish on ViewRay as 1-year prostate data adds to data compendium
06/16/20 Cantor Fitzgerald
ViewRay assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
ViewRay assumed with an Overweight at Cantor Fitzgerald
04/28/20 Guggenheim
ViewRay downgraded to Neutral on hospital budget strain at Guggenheim
VRAY ViewRay
$2.28 /

+0.165 (+7.80%)

VAR Varian Medical
$121.70 /

+2.53 (+2.12%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

ARAY Accuray
$2.12 /

+0.07 (+3.42%)

  • 04
    Dec
BAYRY Bayer
$0.00 /

+ (+0.00%)

VRAY ViewRay
$2.28 /

+0.165 (+7.80%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

Tuesday
Conference/Events
American Association of Physicians in Medicine to hold a virtual meeting » 08:43
07/14/20
07/14
08:43
07/14/20
08:43
ARAY

Accuray

$2.05 /

-0.03 (-1.45%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

, VAR

Varian Medical

$119.17 /

+0.22 (+0.18%)

, VRAY

ViewRay

$2.12 /

-0.075 (-3.42%)

2020 Joint AAPM COMP…

2020 Joint AAPM COMP Virtual Meeting will be held on July 12-16. Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$2.12 /

-0.075 (-3.42%)

VAR Varian Medical
$119.17 /

+0.22 (+0.18%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

ARAY Accuray
$2.05 /

-0.03 (-1.45%)

ARAY Accuray
$2.05 /

-0.03 (-1.45%)

04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

07/02/20 JPMorgan
Siemens Healthineers price target lowered to EUR 37.60 at JPMorgan
06/08/20 Citi
Siemens Healthineers upgraded to Buy from Neutral at Citi
06/05/20 Exane BNP Paribas
Siemens Healthineers downgraded to Neutral from Outperform at Exane BNP Paribas
05/26/20 Berenberg
Siemens Healthineers price target raised to EUR 52 from EUR 40 at Berenberg
VAR Varian Medical
$119.17 /

+0.22 (+0.18%)

06/18/20 UBS
Varian Medical competitive position remains strong, says UBS
05/12/20 Piper Sandler
Piper Sandler notes goodwill impairment charge for Varian Medical investors
05/05/20 Barrington
Varian Medical price target lowered to $137 from $147 at Barrington
05/05/20 Piper Sandler
Varian Medical price target raised to $130 from $126 at Piper Sandler
VRAY ViewRay
$2.12 /

-0.075 (-3.42%)

06/23/20 Piper Sandler
Piper Sandler bullish on ViewRay as 1-year prostate data adds to data compendium
06/16/20 Cantor Fitzgerald
ViewRay assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
ViewRay assumed with an Overweight at Cantor Fitzgerald
04/28/20 Guggenheim
ViewRay downgraded to Neutral on hospital budget strain at Guggenheim
VRAY ViewRay
$2.12 /

-0.075 (-3.42%)

VAR Varian Medical
$119.17 /

+0.22 (+0.18%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

ARAY Accuray
$2.05 /

-0.03 (-1.45%)

  • 04
    Dec
BAYRY Bayer
$0.00 /

+ (+0.00%)

VRAY ViewRay
$2.12 /

-0.075 (-3.42%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

Over a week ago
Recommendations
Varian Medical competitive position remains strong, says UBS » 07:34
06/18/20
06/18
07:34
06/18/20
07:34
VAR

Varian Medical

$118.43 /

+0.8 (+0.68%)

UBS analyst Matthew…

UBS analyst Matthew Taylor keeps his Buy rating and $150 price target on Varian Medical after holding a call with its management. The analyst says the discussion focused on the company's "strong recovery" in China, its "very active" U.S. business funnel as most customers have returned to normal business conditions and its improving "net promoter score" through the outbreak of COVID-19.

ShowHide Related Items >><<
VAR Varian Medical
$118.43 /

+0.8 (+0.68%)

VAR Varian Medical
$118.43 /

+0.8 (+0.68%)

05/12/20 Piper Sandler
Piper Sandler notes goodwill impairment charge for Varian Medical investors
05/05/20 Barrington
Varian Medical price target lowered to $137 from $147 at Barrington
05/05/20 Piper Sandler
Varian Medical price target raised to $130 from $126 at Piper Sandler
04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
VAR Varian Medical
$118.43 /

+0.8 (+0.68%)

Over a month ago
Hot Stocks
RaySearch enters into interoperability agreement with Varian Medical » 07:24
05/28/20
05/28
07:24
05/28/20
07:24
VAR

Varian Medical

$121.69 /

+3.325 (+2.81%)

RaySearch Laboratories…

RaySearch Laboratories and Varian Medical Systems have entered into an interoperability agreement that will allow the RayCare oncology information system to connect to Varian TrueBeam linear accelerators. The ability to schedule radiation treatments and keep track of the treatment progress is a key functionality in an oncology information system. Under the announced agreement, a dedicated interface has been defined which allows RayCare and Varian TrueBeam to communicate the data necessary for an integrated workflow. This means that clinics will be able to use RayCare to manage all clinical activities around their Varian TrueBeam accelerators. The development of the interface is already ongoing, and the target is to release it before the end of 2020. Commercial availability will be subject to regulatory clearance in some markets.

ShowHide Related Items >><<
VAR Varian Medical
$121.69 /

+3.325 (+2.81%)

VAR Varian Medical
$121.69 /

+3.325 (+2.81%)

05/12/20 Piper Sandler
Piper Sandler notes goodwill impairment charge for Varian Medical investors
05/05/20 Barrington
Varian Medical price target lowered to $137 from $147 at Barrington
05/05/20 Piper Sandler
Varian Medical price target raised to $130 from $126 at Piper Sandler
04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
VAR Varian Medical
$121.69 /

+3.325 (+2.81%)

Recommendations
Piper Sandler notes goodwill impairment charge for Varian Medical investors » 19:55
05/12/20
05/12
19:55
05/12/20
19:55
VAR

Varian Medical

$119.36 /

-2.08 (-1.71%)

Piper Sandler analyst…

Piper Sandler analyst Jason Bednar keeps his Overweight rating and $130 price target on Varian Medical, but notes that investors should be aware of the $164M triggering event causing an interim impairment test of the $164M in Interventional Solutions goodwill disclosed by the company in today's 10-Q filing. The analyst further points to the filing stating that the company's Beijing manufacturing facility had a 4-week shutdown, while its U.S. facilities were in critical operations mode" for about 3 weeks.

ShowHide Related Items >><<
VAR Varian Medical
$119.36 /

-2.08 (-1.71%)

VAR Varian Medical
$119.36 /

-2.08 (-1.71%)

05/05/20 Barrington
Varian Medical price target lowered to $137 from $147 at Barrington
05/05/20 Piper Sandler
Varian Medical price target raised to $130 from $126 at Piper Sandler
04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
04/09/20 Evercore ISI
Varian Medical downgraded to Underperform from In Line at Evercore ISI
VAR Varian Medical
$119.36 /

-2.08 (-1.71%)

Hot Stocks
Varian Medical discloses $164M in goodwill impairment charge » 19:51
05/12/20
05/12
19:51
05/12/20
19:51
VAR

Varian Medical

$119.36 /

-2.08 (-1.71%)

As part of its 10-Q filed…

As part of its 10-Q filed earlier today, Varian Medical states: "Due to certain indicators identified related to the Company's Interventional Solutions reporting unit in the second quarter of fiscal year 2020, including a significant decrease in near term revenue projections due to COVID-19, the Company identified a triggering event and performed an interim impairment test on its $164.3 million of goodwill in its Interventional Solutions reporting unit, within the Other reportable operating segment. The fair value of the Interventional Solutions' reporting unit was in excess of its carrying value by approximately $20 million, or 7%. Management believes the methodology and assumptions used to calculate the fair value to be reasonable. However, the Interventional Solutions reporting unit could be at risk for a future goodwill impairment if there are adjustments to certain assumptions used in the fair value calculation, including revenue growth rates, operating margins, and weighted-average cost of capital and/or working capital requirements. Given the uncertain impact of COVID-19 and/or other market factors on the Company's business, its cash flow projections for this business could decrease in the future, which could lead to an impairment of goodwill."

ShowHide Related Items >><<
VAR Varian Medical
$119.36 /

-2.08 (-1.71%)

VAR Varian Medical
$119.36 /

-2.08 (-1.71%)

05/05/20 Barrington
Varian Medical price target lowered to $137 from $147 at Barrington
05/05/20 Piper Sandler
Varian Medical price target raised to $130 from $126 at Piper Sandler
04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
04/09/20 Evercore ISI
Varian Medical downgraded to Underperform from In Line at Evercore ISI
VAR Varian Medical
$119.36 /

-2.08 (-1.71%)

Conference/Events
Varian Medical participates in a conference call with JPMorgan » 13:25
05/08/20
05/08
13:25
05/08/20
13:25
VAR

Varian Medical

$118.79 /

+1.79 (+1.53%)

Life Science Analyst…

Life Science Analyst Peterson holds a conference call with CEO Wilson on May 8 at 2 pm.

ShowHide Related Items >><<
VAR Varian Medical
$118.79 /

+1.79 (+1.53%)

05/05/20 Barrington
Varian Medical price target lowered to $137 from $147 at Barrington
05/05/20 Piper Sandler
Varian Medical price target raised to $130 from $126 at Piper Sandler
04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
04/09/20 Evercore ISI
Varian Medical downgraded to Underperform from In Line at Evercore ISI
Conference/Events
Varian Medical participates in a conference call with JPMorgan » 04:55
05/08/20
05/08
04:55
05/08/20
04:55
VAR

Varian Medical

$117.00 /

+0.85 (+0.73%)

Life Science Analyst…

Life Science Analyst Peterson holds a conference call with CEO Wilson on May 8 at 2 pm.

ShowHide Related Items >><<
VAR Varian Medical
$117.00 /

+0.85 (+0.73%)

05/05/20 Barrington
Varian Medical price target lowered to $137 from $147 at Barrington
05/05/20 Piper Sandler
Varian Medical price target raised to $130 from $126 at Piper Sandler
04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
04/09/20 Evercore ISI
Varian Medical downgraded to Underperform from In Line at Evercore ISI
Recommendations
Varian Medical price target lowered to $137 from $147 at Barrington » 09:00
05/05/20
05/05
09:00
05/05/20
09:00
VAR

Varian Medical

$114.44 /

+3.165 (+2.84%)

Barrington analyst…

Barrington analyst Michael Petusky lowered the firm's price target on Varian Medical to $137 from $147 and keeps an Outperform rating on the shares following the company's weaker than expected Q2 results. The analyst reduced expectations for Varian's near-term profitability due to the fallout from COVID-19.

ShowHide Related Items >><<
VAR Varian Medical
$114.44 /

+3.165 (+2.84%)

05/05/20 Piper Sandler
Varian Medical price target raised to $130 from $126 at Piper Sandler
04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
04/09/20 Evercore ISI
Varian Medical downgraded to Underperform from In Line at Evercore ISI
04/09/20 Evercore ISI
Varian Medical downgraded to Underperform from Outperform at Evercore ISI

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.